THE SAGE GROUP Announces that Mary L. Yost, President, Will Present Several Lectures on Peripheral Artery Disease (PAD), Critical Limb Ischemia (CLI) and Amputation at the 17th Annual NEW CARDIOVASCULAR HORIZONS (NCVH) Meeting

BEAUFORT, S.C.–(BUSINESS WIRE)–Ms. Yost’s lecture titled, “New Research on Peripheral Arterial Disease
Risk Factors” will be delivered on June 1, 2016 at 10:00 AM during the
NCVH Podiatry and Wound Care Session I: Vascular Disease, Diagnosis and
Treatment. Two additional lectures titled “Socio-Economic Costs and
Consequences of Amputation” and “Economic Cost of Peripheral Artery
Disease (PAD), Critical Limb Ischemia (CLI) and Venous Disease: How Big
is the Market?” will be presented at Podiatry and Wound Care Session IV:
The Business of Wound Care held on June 3rd from 9:45 AM to 11:55 AM.

Ms. Yost delivers a lecture on global CLI epidemiology “The Scope of
Critical Limb Ischemia (CLI): A Worldwide Problem” at 10:00 AM during
the 12th Annual CLI Summit Session I on June 2. All NCVH sessions will
be held at The Roosevelt Waldorf-Astoria in New Orleans, Louisiana.

“I am honored to have the opportunity to speak at this prestigious,
multidisciplinary meeting with its special focus on PAD and CLI,”
commented Yost. “PAD has been characterized as a ‘global pandemic.’ Its
rapid spread reflects a combination of factors, particularly the
worldwide epidemic of diabetes and the aging population. Unfortunately,
CLI, the most severe and deadly form of PAD, and resulting amputations
also represent significant global problems. Yet PAD/CLI remain
underestimated, underdiagnosed, undertreated and under-researched.”

For more information on NCVH, including the conference program, or to
register, visit

About NCVH

NCVH is an educational nonprofit foundation focused on multidisciplinary
accredited conferences to advance the field of cardiovascular care using
endovascular technologies, pharmacotherapy treatments, peripheral
interventions and amputation prevention techniques. With a goal to
empower healthcare providers with knowledge of head-to-toe vascular
treatments, NCVH strives to promote interdisciplinary teamwork and
collaboration to address the continuum of patient care. Additional


THE SAGE GROUP, a research and consulting company, specializes in
atherosclerotic and venous disease in the lower limbs, specifically PAD,
CLI, intermittent claudication (IC) and ischemic diabetic foot ulcers
(DFU). The most recent research focuses on quantifying the economic and
social costs of PAD, CLI and amputation. Additional information:


Mary Yost, 404-520-6652